The effect of hydrocortisone on neurodevelopmental outcome in premature infants less than 29 weeks gestation

Howard William Needelman, Arvind Hoskappal, Holly Jean Roberts, Martha Evans, J. B. Bodensteiner

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The use of postnatal dexamethasone in premature newborns can be associated with a deleterious neurodevelopmental outcome. The effect of hydrocortisone on developmental outcome in these patients is less clear. We therefore sought to examine the effect of hydrocortisone on early developmental outcome in premature newborns. We retrospectively examined the effect of hydrocortisone on developmental outcome during the first 2 years of life in premature infants <29 weeks gestation at birth. Even though hydrocortisone was used in infants with a greater risk for poor outcome, its use, unless prolonged >7 days, was generally not associated with a worse developmental outcome or higher rate of referral for early intervention. A short course of hydrocortisone in sick premature newborns does not appear to have a deleterious effect on developmental outcome.

Original languageEnglish (US)
Pages (from-to)448-452
Number of pages5
JournalJournal of Child Neurology
Volume25
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Premature Infants
Hydrocortisone
Pregnancy
Newborn Infant
Dexamethasone
Referral and Consultation

Keywords

  • Early intervention
  • Hydrocortisone
  • NICU developmental outcome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

The effect of hydrocortisone on neurodevelopmental outcome in premature infants less than 29 weeks gestation. / Needelman, Howard William; Hoskappal, Arvind; Roberts, Holly Jean; Evans, Martha; Bodensteiner, J. B.

In: Journal of Child Neurology, Vol. 25, No. 4, 04.2010, p. 448-452.

Research output: Contribution to journalArticle

@article{2c024eb107fa4badb7e116b2972fb7f3,
title = "The effect of hydrocortisone on neurodevelopmental outcome in premature infants less than 29 weeks gestation",
abstract = "The use of postnatal dexamethasone in premature newborns can be associated with a deleterious neurodevelopmental outcome. The effect of hydrocortisone on developmental outcome in these patients is less clear. We therefore sought to examine the effect of hydrocortisone on early developmental outcome in premature newborns. We retrospectively examined the effect of hydrocortisone on developmental outcome during the first 2 years of life in premature infants <29 weeks gestation at birth. Even though hydrocortisone was used in infants with a greater risk for poor outcome, its use, unless prolonged >7 days, was generally not associated with a worse developmental outcome or higher rate of referral for early intervention. A short course of hydrocortisone in sick premature newborns does not appear to have a deleterious effect on developmental outcome.",
keywords = "Early intervention, Hydrocortisone, NICU developmental outcome",
author = "Needelman, {Howard William} and Arvind Hoskappal and Roberts, {Holly Jean} and Martha Evans and Bodensteiner, {J. B.}",
year = "2010",
month = "4",
doi = "10.1177/0883073809348059",
language = "English (US)",
volume = "25",
pages = "448--452",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - The effect of hydrocortisone on neurodevelopmental outcome in premature infants less than 29 weeks gestation

AU - Needelman, Howard William

AU - Hoskappal, Arvind

AU - Roberts, Holly Jean

AU - Evans, Martha

AU - Bodensteiner, J. B.

PY - 2010/4

Y1 - 2010/4

N2 - The use of postnatal dexamethasone in premature newborns can be associated with a deleterious neurodevelopmental outcome. The effect of hydrocortisone on developmental outcome in these patients is less clear. We therefore sought to examine the effect of hydrocortisone on early developmental outcome in premature newborns. We retrospectively examined the effect of hydrocortisone on developmental outcome during the first 2 years of life in premature infants <29 weeks gestation at birth. Even though hydrocortisone was used in infants with a greater risk for poor outcome, its use, unless prolonged >7 days, was generally not associated with a worse developmental outcome or higher rate of referral for early intervention. A short course of hydrocortisone in sick premature newborns does not appear to have a deleterious effect on developmental outcome.

AB - The use of postnatal dexamethasone in premature newborns can be associated with a deleterious neurodevelopmental outcome. The effect of hydrocortisone on developmental outcome in these patients is less clear. We therefore sought to examine the effect of hydrocortisone on early developmental outcome in premature newborns. We retrospectively examined the effect of hydrocortisone on developmental outcome during the first 2 years of life in premature infants <29 weeks gestation at birth. Even though hydrocortisone was used in infants with a greater risk for poor outcome, its use, unless prolonged >7 days, was generally not associated with a worse developmental outcome or higher rate of referral for early intervention. A short course of hydrocortisone in sick premature newborns does not appear to have a deleterious effect on developmental outcome.

KW - Early intervention

KW - Hydrocortisone

KW - NICU developmental outcome

UR - http://www.scopus.com/inward/record.url?scp=77950951093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950951093&partnerID=8YFLogxK

U2 - 10.1177/0883073809348059

DO - 10.1177/0883073809348059

M3 - Article

C2 - 20139411

AN - SCOPUS:77950951093

VL - 25

SP - 448

EP - 452

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 4

ER -